Furthermore, our study indicates that SPP1, CD36, ATP6V0D2, CHI3L1, MYH11, and BDNF, which showed favorable diagnostic performance and high correlations with several clinical biochemical parameters, may potentially serve as biomarkers to diagnose and monitor the prognosis of atherosclerosis. This evidence concerns the gene BDNF and atherosclerosis.